Avant Brands Inc., a company operating within the Health Care sector and specifically in the Pharmaceuticals industry, is listed on the Toronto Stock Exchange. As of February 18, 2026, the company’s stock closed at 0.83 CAD. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of 1.44 CAD on March 2, 2025, and a 52-week low of 0.56 CAD on October 27, 2025. This range indicates a moderate potential for upside relative to its current trading levels.
Avant Brands Inc. is primarily known for its operations in the cannabis industry in Canada, where it focuses on the manufacturing, distribution, and marketing of handcrafted cannabis products across the nation. Despite its niche market, the company has not reported any significant updates since January 10, 2026, when it announced a shareholder-rights plan. This plan is often indicative of a company’s efforts to protect itself from hostile takeovers, suggesting that Avant Brands may be undergoing strategic restructuring.
Financially, Avant Brands Inc. presents a challenging picture. The company’s price-to-earnings (P/E) ratio stands at -0.424, which typically signals that the company is either not profitable or experiencing highly volatile earnings. Additionally, the price-to-book (P/B) ratio is 0.344, indicating that the stock is trading well below its book value. This valuation suggests that the market has lower expectations for the company’s asset backing and future profitability.
The combination of a negative P/E ratio and a low P/B ratio, along with the implementation of a shareholder-rights plan, suggests that Avant Brands is in a phase of restructuring. The company’s modest price volatility further supports this view, as it reflects a market perception of uncertainty regarding its financial stability and growth prospects. With a market capitalization of 10,040,000 CAD, Avant Brands remains a relatively small player in the cannabis industry, facing significant challenges in achieving profitability and market confidence.
